Subsequent Events |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Subsequent Events [Abstract] | |
| Subsequent Events | 13. Subsequent Events Private Placement Financing On August 7, 2026, the Company entered into a Stock Purchase Agreement with the National MPS Society and the Cure Sanfilippo Foundation (the “Purchasers”), pursuant to which the Company sold and issued to the Purchasers 121,203 shares of common stock in a private placement transaction. The purchase price per share of common stock is $45.38 per share. The total gross proceeds to the Company was $5.5 million. The proceeds will be used to partially fund the Company’s planned open-label, single-arm early access program to provide TA-ERT for the treatment of MPS IIIB in children. |